{"&cites=6104111072169565449&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"10-year follow-up of intensive glucose control in type 2 diabetes","url":"https://www.nejm.org/doi/full/10.1056/nejmoa0806470","authors":["RR Holman","RR Holman SK Paul","RR Holman SK Paul MA Bethel…"],"year":2008,"numCitations":7777,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa0806470","citationUrl":"http://scholar.google.com/scholar?cites=12357987943635156858&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ev_uLo9kgKsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12357987943635156858&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc","p":1,"exp":1596879449187},{"title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa021778","authors":["P Gæde","P Gæde P Vedel","P Gæde P Vedel N Larsen","P Gæde P Vedel N Larsen GVH Jensen…"],"year":2003,"numCitations":5485,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa021778","citationUrl":"http://scholar.google.com/scholar?cites=5125387538833457608&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:yMFhpM8IIUcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5125387538833457608&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised …","url":"https://www.sciencedirect.com/science/article/pii/S0140673604168955","authors":["HM Colhoun","HM Colhoun DJ Betteridge","HM Colhoun DJ Betteridge PN Durrington","HM Colhoun DJ Betteridge PN Durrington GA Hitman…"],"year":2004,"numCitations":4682,"pdf":"https://www.researchgate.net/profile/Mike_Mackness/publication/8386001_Primary_prevention_of_cardiovascular_disease_with_atorvastatin_in_type_2_diabetes_in_the_Collaborative_Atorvastatin_Diabetes_Study_CARDS_Multicentre_randomised_placebo-controlled_trial/links/5a2a9b5a0f7e9b63e538aa29/Primary-prevention-of-cardiovascular-disease-with-atorvastatin-in-type-2-diabetes-in-the-Collaborative-Atorvastatin-Diabetes-Study-CARDS-Multicentre-randomised-placebo-controlled-trial.pdf","citationUrl":"http://scholar.google.com/scholar?cites=12415936138849944661&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:VQQWxiJETqwJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12415936138849944661&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673603136367","authors":["Heart Protection Study Collaborative Group"],"year":2003,"numCitations":3502,"citationUrl":"http://scholar.google.com/scholar?cites=8435384778789658821&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:xaB-g8OBEHUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8435384778789658821&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","url":"https://jamanetwork.com/journals/jama/article-abstract/194038","authors":["HC Gerstein","HC Gerstein JFE Mann","HC Gerstein JFE Mann Q Yi","HC Gerstein JFE Mann Q Yi B Zinman","HC Gerstein JFE Mann Q Yi B Zinman SF Dinneen…"],"year":2001,"numCitations":2754,"pdf":"https://jamanetwork.com/journals/jama/fullarticle/194038","citationUrl":"http://scholar.google.com/scholar?cites=5659569748885332089&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:eWDbb7PUik4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5659569748885332089&hl=en&as_sdt=2005&sciodt=0,5","publication":"jamanetwork.com"},{"title":"Effects of combination lipid therapy in type 2 diabetes mellitus","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1001282","authors":["ACCORD Study Group"],"year":2010,"numCitations":2654,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1001282","citationUrl":"http://scholar.google.com/scholar?cites=15423001503682629592&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:2I9RLSeCCdYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15423001503682629592&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","url":"https://www.acpjournals.org/doi/abs/10.7326/0003-4819-141-6-200409210-00007","authors":["E Selvin","E Selvin S Marinopoulos","E Selvin S Marinopoulos G Berkenblit…"],"year":2004,"numCitations":2123,"pdf":"https://academic.csuohio.edu/jdemarco/Neuroethics/Diabetes/Diabetes_CVD.pdf","citationUrl":"http://scholar.google.com/scholar?cites=18368373687418458218&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:apA1hIyS6f4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18368373687418458218&hl=en&as_sdt=2005&sciodt=0,5","publication":"acpjournals.org"},{"title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)","url":"https://www.sciencedirect.com/science/article/pii/S0085253815488635","authors":["AI Adler","AI Adler RJ Stevens","AI Adler RJ Stevens SE Manley","AI Adler RJ Stevens SE Manley RW Bilous","AI Adler RJ Stevens SE Manley RW Bilous CA Cull…"],"year":2003,"numCitations":1981,"pdf":"https://www.sciencedirect.com/science/article/pii/S0085253815488635","citationUrl":"http://scholar.google.com/scholar?cites=14306344974971817815&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:V89j2_RYisYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14306344974971817815&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1 …","url":"https://www.atherosclerosis-journal.com/article/S0021-9150(98)90209-X/abstract","authors":["D Wood","D Wood G De Backer","D Wood G De Backer O Faergeman…"],"year":1998,"numCitations":1923,"citationUrl":"http://scholar.google.com/scholar?cites=3648835742358616403&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:U7kIe8ZEozIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3648835742358616403&hl=en&as_sdt=2005&sciodt=0,5","publication":"atherosclerosis-journal.com"},{"title":"Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society …","url":"https://academic.oup.com/eurheartj/article-abstract/27/11/1341/454818","authors":["Authors/Task Force Members","Authors/Task Force Members K Fox…"],"year":2006,"numCitations":1894,"pdf":"https://academic.oup.com/eurheartj/article/27/11/1341/454818","citationUrl":"http://scholar.google.com/scholar?cites=2928575412624287422&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:vuZpT9JjpCgJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2928575412624287422&hl=en&as_sdt=2005&sciodt=0,5","publication":"academic.oup.com"}]}